Excited to share my #Top5 in #breastcancer from #ASCO25 #bcsm @osuwexmed.bsky.social www.vumedi.com/video/ascor-...

Last training ride before #pelotonia25. Since May, I’ve spent 30 hours and traveled more than 360 miles so that next Saturday I will ride 50 miles with more than 7,000 of my closest friends to help support #CancerResearch #onegoal #LetsDoThis #FuelMyRide ➡️ www.pelotonia.org/profile/MG0328

@oncoalert.bsky.social annual #ASCO25 5K on a beautiful morning in Chicago! Had some great running partners this am @quirogad.bsky.social @christeeny513.bsky.social

#ASCO25 has started! Great catching up with @drsgraff.bsky.social and Dr Gao!

Wonderful time giving grand rounds today at #Georgetown There’s nothing quite like going “home” to your alma mater and seeing all the amazing preceptors and mentors that so positively impacted your life #HoyaSaxa

Beautiful morning on campus with Buckeye grove in bloom @osuwexmed.bsky.social @osucccjames.bsky.social

Today family picture with some of the 87 amazing faculty of our Division of Medical Oncology at The James CCC. Very honored to be part and lead this incredible team! @OhioStateMedOnc @OSUCCC_James @OhioStateMed @drgattimays.bsky.social @stoverlab.bsky.social

Honored and grateful for the opportunity to discuss 3 oral abstracts at #ASCO25 and represent #OSUCCC @osucccjames.bsky.social @osuwexmed.bsky.social #Immunotherapy @sitcancer.bsky.social #PIIO @ascocancer.bsky.social

Passed this every day in Building 10 on the way to my office at the NIH. “…look to the service from the healthcare givers at the NIH. It is where knowledge, pride and love is given from each healthcare giver; To heal and comfort the sick and afflicted helping to give a brand new start”

Always fun to speak to graduate students about the importance of the work they do in the lab and show them how their work is translated 🧬🧫 -> 🛌 🩻 to benefit patients I see in clinic #Research #AcademicMedicine #Oncology @osuwexmed.bsky.social @osucccjames.bsky.social

Did you know? 99% of all new medications resulted from federally-funded university research through #NIH Learn more about #ResearchSavesLives: hub.jhu.edu/research-sav....

Patient education on #BreastCancer #Subtypes with #PatientPower @osuwexmed.bsky.social @osucccjames.bsky.social #bcsm www.patientpower.info/video/breast...

#THEOhioState is a great place to work #GoBucks #AcademicJobs

Bravo @stoverlab.bsky.social 👏👏

Deadline approaching! The #SITC Women in Cancer Immunotherapy Network Leadership Institute applications close March 24. Don’t miss your opportunity to participate in panel discussions and presentations from experienced female leaders. Learn more here: www.sitcancer.org/professional...

#Immunotherapy can induce cutaneous sarcoid #irAE @osucccjames.bsky.social @osuwexmed.bsky.social www.frontiersin.orgundefined/journals/imm...

New Journal for ImmunoTherapy of Cancer ( #JITC ) position article and guidelines: Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols bit.ly/4hlPSMw

On International Women’s Day we honor the past, present, and future contributions of women who make our state stronger.

Looking for your first faculty position? Or perhaps new start? THE Ohio State University Comprehensive Cancer Center (Columbus, OH) is hiring in several #MedOnc sections - GI, Thoracic, Breast, Neuroendocrine, cutaneous. #AcademicJobs #OSUCCC @osucccjames.bsky.social @christianrolfo.bsky.social

Apply now for a one-year, $100,000 SITC Diversity, Equity and Inclusion Fellowship. Letter of Intent due on March 12. #SITCFellowship #ECR sitcancer.org/sitc2025

So excited for @sitcancer.bsky.social #ACI #WomensMalignancies that is about to start 11am EST

Some days I just really feel this #AcademicMedicine

Discuss real-world case studies with clinical experts! #SITC’s ACI: Women’s Malignancies program will explore practical insights to apply immunotherapy into clinical practice. Join Feb. 28 for a free CME program. Register now: ow.ly/bTFn50UYy9j @drgattimays.bsky.social @veredstearns.bsky.social

This 👇💪

Fly Eagles Fly!!! 🦅

In Ohio during FY23 (2022-2023) this was the impact of NIH funding: $1.01 Billion in grants and contracts $2.05 Billion in economic support 13,061 jobs supported This reduction in NIH indirect will decimate research and limit health care advances www.unitedformedicalresearch.org/nih-in-your-...

Great session with Dr Heather McArthur on treating early stage #TNBC #IO posted on #ReachMD @osuwexmed.bsky.social @osucccjames.bsky.social reachmd.com/programs/cme...

Happy to share our retrospective study on #pneumonitis risk in patients with #breastcancer who receive #TDXd #Enhertu @stoverlab.bsky.social @osucccjames.bsky.social #bcsm

Recognizing the brilliant #WomenInMedicine today 2/3/25 who continue to persevere, break glass ceilings and improve healthcare #NWPD25 #IamBlackwell @quirogad.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @maryamlustberg.bsky.social

📚🎙️Come discuss updates and the future of IO use in #MBC with me on Feb 28th! A++ group of #breastonc #gynonc speakers and great opportunity for CME/MOC and other ed credits @sitcancer.bsky.social #LearnACI #bcsm @drgattimays.bsky.social @osucccjames.bsky.social

Amazing group of medical oncologists that I am privileged to work with every day and call friends @stoverlab.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @quirogad.bsky.social @osucccjames.bsky.social

Great session by Kevin Kalinsky of @emoryuniversity.bsky.social on overcoming endocrine resistance in ER+ #BreastCancer at the @osucccjames.bsky.social #SABCS Update

The FDA has approved trastuzumab deruxtecan (T-DXd) for patients with HR-positive, HER2-low, or HER2-ultralow metastatic breast cancer based on DESTINY-Breast06 trial results. #BreastCancer #Oncology ascopost.com/news/january...

Join us 2/1/25 at the Hilton Columbus at Easton @osucccjames.bsky.social Update from the #SABCS24 👋Experts from #TheJames @mskcancercenter.bsky.social #Emory will address the latest insights and practical guidance presented at #SABCS24. Register here 👉 ccme.osu.edu/continuing-m...

Fantastic USC Keck SOM Breast Cancer Symposium with great faculty, fellow cases, and new collaborations. Offering my support to all those here in LA impacted by the wildfire devastation.

Great segment on @nbc4i.bsky.social by @stoverlab.bsky.social @osucccjames.bsky.social on the recent #ACS cancer stats www.nbc4i.com/video/annual...

#GoBucks 💪🎉 @ohiostatefb.bsky.social O-H

Looking for your first faculty position? Or perhaps new start? THE Ohio State University Comprehensive Cancer Center (Columbus, OH) is hiring in several #MedOnc sections - GI, Thoracic, Breast, Neuroendocrine, cutaneous. #AcademicJobs #OSUCCC @osucccjames.bsky.social @christianrolfo.bsky.social

What do we know about how the biology of mammary gland lactation and involution impact breast cancer risk? Building on work from Dr. Pepper Schedin & many others, new work in #BreastCancerResearch from Ramaswamy Lab @osucccjames.bsky.social link.springer.com/article/10.1...

Join us 2/1/25 at the Hilton Columbus at Easton @osucccjames.bsky.social Update from the #SABCS24 👋Experts from #TheJames @mskcancercenter.bsky.social #Emory will address the latest insights and practical guidance presented at #SABCS24. Register here 👉 ccme.osu.edu/continuing-m...

My take on the #Top5 🔑 studies presented at #SABCS24 for #VuMedi #bcsm #breastcancer @osucccjames.bsky.social @osuwexmed.bsky.social @sabcs.bsky.social

Yes!!! #GoBucks

First run of 2025 complete with some ❄️ Wishing you all a healthy and happy 2025! #LetsDoThis #Mindfulness #Selfcare #WorkLifeJuggle

Agree 100% @stoverlab.bsky.social - these fractions of a point difference that carry so much weigh usually equate to a handful of patients out of 100 that gives a 4 out of 5 (instead of 5 of 5) on the likert scale.

2024 approvals: Summary of 14 new drugs/indications in #LungCancer by FDA 1. #Tepotinib 2. #Osimertinib x2 3. #Alectinib 4. #Tarlatamab 5. #Zenocutuzumab 6. #Durvalumab x2 7. #Amivantamab x2 8. #Nivolumab (now SubQ) 9. #Ensartinib #lcsm #OncSky #MedSky #Cancer

🚨 BREAKING 🚨: @fda.gov Approves Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors #oncology www.onclive.com/view/fda-app...

Whether it's volunteering at a local school or taking soup to a sick neighbor, improving the welfare of others can also improve our own physical and mental health, a sizable body of research shows.